November 2, 2016
Shire doubles third quarter revenues, operates with net loss in Q3
Shire doubles third quarter revenues, operates with net loss in Q3
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Flemming Ornskov
January 12, 2016
Drugmaker Shire to buy Baxalta for $32 billion after six-month pursuit
Drugmaker Shire Plc clinched its six-month pursuit of Baxalta International Inc on Monday with an agreed $32 billion (22 billion pound) cash and stock offer, catapulting it to a leading position in treating rare diseases.
October 19, 2015
Shire disappointed, wating lifitegrast, OPUS-3 study, data
“We were disappointed, but will soon have data from the Phase 3 study, OPUS 3,” said Flemming Ornskov, M.D., CEO, Shire.